Skip to main content

Raleigh startup raises $36M to advance COPD treatment

A small company in Raleigh is moving its lead drug candidate into clinical trials after closing a $36M funding round.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.